Publishing research using ab9957? Please let us know so that we can cite the reference in this datasheet.

ab9957 has been referenced in 8 publications.

  • Beier EE  et al. Elevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent Mice. Toxicol Sci 149:277-88 (2016). PubMed: 26518054
  • Li XJ  et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-?B signaling pathways in osteoprotegerin knockout mice. Int J Mol Med N/A:N/A (2016). WB ; Mouse . PubMed: 27840967
  • Terasawa K  et al. Preferential recognition of isocitrate dehydrogenase by a rabbit monoclonal antibody (ab124797) against the C-terminal peptide of RANKL. J Immunol Methods N/A:N/A (2015). PubMed: 25771969
  • Szwarc MM  et al. Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors. PLoS One 10:e0128467 (2015). WB ; Mouse . PubMed: 26061636
  • Irie K  et al. Impact of the Oral Commensal Flora on Alveolar Bone Homeostasis. J Dent Res 93:801-806 (2014). PubMed: 24935067
  • Peng X  et al. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer. PLoS One 8:e58361 (2013). WB, IHC-P ; Human . PubMed: 23516466
  • Mediero A  et al. Adenosine A2A receptor activation prevents wear particle-induced osteolysis. Sci Transl Med 4:135ra65 (2012). IHC-P ; Mouse . PubMed: 22623741
  • Ndip A  et al. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes 60:2187-96 (2011). IHC-P ; Human . PubMed: 21659498

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"